X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (68) 68
male (58) 58
index medicus (52) 52
female (50) 50
adult (44) 44
middle aged (43) 43
aged (40) 40
oncology (36) 36
animals (20) 20
glioblastoma (19) 19
prognosis (19) 19
treatment outcome (17) 17
cancer (16) 16
clinical neurology (16) 16
young adult (15) 15
aged, 80 and over (14) 14
retrospective studies (14) 14
temozolomide (14) 14
adolescent (13) 13
brain neoplasms - mortality (13) 13
care and treatment (13) 13
chemotherapy (13) 13
brain neoplasms - drug therapy (12) 12
교육학 (12) 12
glioblastoma - drug therapy (11) 11
glioma (11) 11
radiotherapy (11) 11
survival rate (11) 11
analysis (10) 10
article (10) 10
cardiac & cardiovascular systems (10) 10
medicine & public health (10) 10
rats (10) 10
research (10) 10
surgery (10) 10
clinical trials (9) 9
drug therapy (9) 9
glioblastoma - mortality (9) 9
original (9) 9
risk factors (9) 9
survival (9) 9
survival analysis (9) 9
therapy (9) 9
antineoplastic combined chemotherapy protocols - therapeutic use (8) 8
biochemistry & molecular biology (8) 8
brain neoplasms - pathology (8) 8
brain neoplasms - radiotherapy (8) 8
brain neoplasms - therapy (8) 8
calculating (8) 8
chemistry (8) 8
computing (8) 8
counting (8) 8
diagnosis (8) 8
disease-free survival (8) 8
electric digital data processing (8) 8
gliomas (8) 8
metallurgy (8) 8
physics (8) 8
antineoplastic agents - therapeutic use (7) 7
brain neoplasms - genetics (7) 7
expression (7) 7
internal medicine (7) 7
mice (7) 7
neurology (7) 7
original article (7) 7
patch-clamp techniques (7) 7
radiation-therapy (7) 7
tumors (7) 7
abridged index medicus (6) 6
apoptosis (6) 6
astrocytoma (6) 6
bevacizumab (6) 6
brain neoplasms - diagnosis (6) 6
channel (6) 6
dacarbazine - analogs & derivatives (6) 6
follow-up studies (6) 6
glioblastoma - genetics (6) 6
glioblastoma - radiotherapy (6) 6
glioblastoma multiforme (6) 6
kaplan-meier estimate (6) 6
neurosciences (6) 6
pharmacology & pharmacy (6) 6
phase-ii trial (6) 6
rats, sprague-dawley (6) 6
advertising (5) 5
arrangements or circuits for control of indicating devicesusing static means to present variable information (5) 5
atrial fibrillation (5) 5
cancer research (5) 5
cardiovascular (5) 5
cryptography (5) 5
dispersion (5) 5
display (5) 5
education (5) 5
electricity (5) 5
elektronenstrahl (5) 5
glioblastoma - pathology (5) 5
handling record carriers (5) 5
hematology (5) 5
hemorrhage (5) 5
medical colleges (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Current Treatment Options in Oncology, ISSN 1527-2729, 12/2018, Volume 19, Issue 12, pp. 1 - 7
The treatment paradigm for anaplastic glioma has shifted, owing to new diagnostic criteria and new phase III clinical trial evidence. In 2016, the WHO... 
PCV | Medicine & Public Health | Anaplastic glioma | Oncology | Temozolomide | Astrocytoma | Oligodendroglioma | LOMUSTINE | PROCARBAZINE | TUMORS | CHEMOTHERAPY | PHASE-III TRIAL | GLIOBLASTOMA | ONCOLOGY | VINCRISTINE | RADIOTHERAPY | Care and treatment | Usage | Gliomas | Analysis | Molecular diagnostic techniques | Clinical trials | Diagnosis
Journal Article
Journal Article
Neuro-Oncology, ISSN 1522-8517, 11/2019, Volume 21, Issue Supplement_6, pp. vi229 - vi229
Abstract Panobinostat (PBST) is a histone deacetylase inhibitor with biologic rationale in the treatment of gliomas harboring H3 K27M mutation. METHODS We... 
Journal Article
Current treatment options in oncology, 10/2018, Volume 19, Issue 12, p. 61
The treatment paradigm for anaplastic glioma has shifted, owing to new diagnostic criteria and new phase III clinical trial evidence. In 2016, the WHO... 
Journal Article
Journal of Arrhythmia, ISSN 1880-4276, 08/2019, Volume 35, Issue 4, pp. 645 - 653
Background Radiofrequency catheter ablation (RFCA) for accessory pathways (APs) at the site of prior valve surgery (VS) remains challenging. We aimed to... 
Ebstein anomaly | catheter ablation | accessory pathway | Wolff‐Parkinson‐White syndrome | prosthetic valve | Cardiac arrhythmia | Prostheses | Laboratories | Surgery | Electrocardiography | Success | Age | Catheters
Journal Article
by Park, JW and Yang, PS and Bae, HJ and Yang, SY and Yu, HT and Kim, TH and Uhm, JS and Joung, B and Lee, MH and Pak, HN
JOURNAL OF THE AMERICAN HEART ASSOCIATION, ISSN 2047-9980, 09/2019, Volume 8, Issue 17, p. e013204
Background-Although it has been reported that renal function can improve after catheter ablation of atrial fibrillation (AF), long-term changes in renal... 
OXIDATIVE STRESS | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | HEART-FAILURE | ANGIOTENSIN-ALDOSTERONE SYSTEM | FOLLOW-UP | catheter ablation | PREVALENCE | atrial fibrillation | CARDIOVASCULAR-DISEASE | RADIOFREQUENCY CATHETER | renal function | RHYTHM | CHRONIC KIDNEY-DISEASE
Journal Article
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2011, Volume 80, Issue 2, pp. 347 - 353
Purpose Amplification of the epidermal growth factor receptor (EGFR) gene represents one of the most frequent gene alterations in glioblastoma (GBM). In the... 
Radiology | Hematology, Oncology and Palliative Medicine | Glioma | Astrocytoma | EGFR | Glioblastoma | FACTOR-RECEPTOR | GLIOMAS | GLIOBLASTOMA-MULTIFORME | RECURRENT GLIOBLASTOMA | RADIATION-THERAPY | TEMOZOLOMIDE | TRIAL | ONCOLOGY | EPIDERMAL-GROWTH-FACTOR | EXPRESSION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | ERLOTINIB | Receptor, Epidermal Growth Factor - genetics | Humans | Middle Aged | Male | Antineoplastic Agents - administration & dosage | Diarrhea - chemically induced | Glioblastoma - radiotherapy | Young Adult | Receptor, Epidermal Growth Factor - metabolism | Glioblastoma - genetics | Antineoplastic Agents - adverse effects | Enzyme Activators - administration & dosage | Adult | Female | Quinazolines - administration & dosage | Brain Neoplasms - mortality | Brain Neoplasms - radiotherapy | Dexamethasone - administration & dosage | Drug Administration Schedule | Genes, erbB-1 - genetics | Brain Neoplasms - genetics | In Situ Hybridization, Fluorescence | Brain Neoplasms - drug therapy | Disease-Free Survival | Chemotherapy, Adjuvant - methods | Quinazolines - adverse effects | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Gene Amplification - genetics | Glioblastoma - drug therapy | Glioblastoma - mortality | Care and treatment | Epidermal growth factor | Gliomas | Oncology, Experimental | Analysis | Clinical trials | Research | Gefitinib | Drug therapy | Cancer | STEROID HORMONES | DEXAMETHASONE | GLUCOCORTICOIDS | NERVOUS SYSTEM | IN-SITU HYBRIDIZATION | MITOGENS | NERVOUS SYSTEM DISEASES | NMR IMAGING | THERAPY | LUMINESCENCE | RADIOLOGY AND NUCLEAR MEDICINE | NUCLEIC ACID HYBRIDIZATION | CORTICOSTEROIDS | BRAIN | BIOTECHNOLOGY | MEMBRANE PROTEINS | DIAGNOSTIC TECHNIQUES | NEOPLASMS | EVALUATION | CENTRAL NERVOUS SYSTEM | ANTINEOPLASTIC DRUGS | GROWTH FACTORS | RECEPTORS | EMISSION | BODY | STEROIDS | ADRENAL HORMONES | ANIMAL TISSUES | MEDICINE | PHOTON EMISSION | HYDROXY COMPOUNDS | EPITHELIUM | EPIDERMIS | GENES | DRUGS | RADIOTHERAPY | SKIN | RADIOLOGY | GENETIC ENGINEERING | ORGANIC COMPOUNDS | PREGNANES | NUCLEAR MEDICINE | KETONES | ORGANS | DISEASES | FLUORESCENCE | PROTEINS | HORMONES
Journal Article
Journal Article
Neuro-Oncology, ISSN 1522-8517, 11/2019, Volume 21, Issue Supplement_6, pp. vi154 - vi154
Abstract BACKGROUND The Tumor Treating Fields (TTF) mechanism of action is hypothesized act upon mitosis by disrupting the cell spindle apparatus. However,... 
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2011, Volume 81, Issue 2, pp. 468 - 475
Background The mammalian target of rapamycin (mTOR) functions within the PI3K/Akt signaling pathway as a critical modulator of cell survival. On the basis of... 
Radiology | Hematology, Oncology and Palliative Medicine | Temozolomide | Fluorodeoxyglucose positron emission tomography | Everolimus | Glioblastoma | Radiation | MAMMALIAN TARGET | RAPAMYCIN | ADVANCED SOLID TUMORS | LIVER-TRANSPLANTATION | ANTICANCER AGENTS | POSITRON-EMISSION-TOMOGRAPHY | METABOLISM | ONCOLOGY | PATHWAY | MTOR INHIBITORS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SIROLIMUS | Dacarbazine - adverse effects | Follow-Up Studies | Brain Neoplasms - diagnostic imaging | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Glioblastoma - radiotherapy | Glioblastoma - diagnostic imaging | Dacarbazine - analogs & derivatives | Adult | Female | Brain Neoplasms - radiotherapy | Radiopharmaceuticals | Sirolimus - adverse effects | Dacarbazine - administration & dosage | Sirolimus - analogs & derivatives | Administration, Oral | Positron-Emission Tomography - methods | Brain Neoplasms - drug therapy | Combined Modality Therapy - adverse effects | Sirolimus - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Fluorodeoxyglucose F18 | Aged | Combined Modality Therapy - methods | Glioblastoma - drug therapy | Care and treatment | Gliomas | Oncology, Experimental | Clinical trials | Product development | Research | Angiogenesis inhibitors | Drug therapy | Radiotherapy | Cancer | Index Medicus | TOMOGRAPHY | DIGESTIVE SYSTEM | EMISSION COMPUTED TOMOGRAPHY | FLUORODEOXYGLUCOSE | STANDARDS | RADIATION DOSES | MEDICINE | ANTIMETABOLITES | NERVOUS SYSTEM DISEASES | THERAPY | GLANDS | POSITRON COMPUTED TOMOGRAPHY | DRUGS | RADIOLOGY AND NUCLEAR MEDICINE | METABOLIC DISEASES | RADIOTHERAPY | COMBINED THERAPY | RADIOLOGY | GLIOMAS | DIAGNOSTIC TECHNIQUES | NEOPLASMS | TOXICITY | COMPUTERIZED TOMOGRAPHY | NUCLEAR MEDICINE | ORGANS | DISEASES | DOSES | LIVER | BODY
Journal Article
American Journal of Obstetrics and Gynecology, ISSN 0002-9378, 2015, Volume 212, Issue 1, pp. S296 - S296
Journal Article
Journal Article